NR1H4 and metabolic dysfunction-associated steatotic liver disease: In MASLD patients, Bacteroidetes activity against bile acid 7α-dehydroxylase is enhanced, resulting in elevated levels of DCA, which impairs the β oxidative capacity of fatty acids in the liver by inhibiting the FXR signaling pathway (Baffy, 2019).